• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟氯喹诱导的心肌病的新临床和超微结构发现——2例报告

New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.

作者信息

Soong T Rinda, Barouch Lili A, Champion Hunter C, Wigley Frederick M, Halushka Marc K

机构信息

Department of Pathology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

出版信息

Hum Pathol. 2007 Dec;38(12):1858-63. doi: 10.1016/j.humpath.2007.06.013.

DOI:10.1016/j.humpath.2007.06.013
PMID:18061791
Abstract

Hydroxychloroquine- or chloroquine -induced cardiomyopathy is a rare but potentially fatal condition. Hydroxychloroquine and chloroquine are often used for long-term treatment of rheumatic diseases and for malaria prophylaxis. Hydroxychloroquine- and chloroquine-induced cardiomyopathy have well-described microscopic features, with the classic electron microscopic findings of myelin figures (myeloid bodies). We report on 2 new cases with novel findings. The first case, in a patient with systemic lupus erythematosus, was found to have megamitochondria in addition to myelin figures seen by electron microscopy. The second report describes the first case of hydroxychloroquine cardiomyopathy described in a patient with scleroderma. These novel findings will add to the present knowledge of hydroxychloroquine-induced cardiomyopathy in its pathology and its implication for treatment of rheumatic diseases.

摘要

羟氯喹或氯喹诱发的心肌病是一种罕见但可能致命的病症。羟氯喹和氯喹常用于长期治疗风湿性疾病及预防疟疾。羟氯喹和氯喹诱发的心肌病具有明确的微观特征,典型的电子显微镜下表现为髓鞘样结构(髓样小体)。我们报告了2例有新发现的病例。第一例是一名系统性红斑狼疮患者,除电子显微镜下可见的髓鞘样结构外,还发现有巨型线粒体。第二篇报告描述了第一例硬皮病患者中出现的羟氯喹心肌病病例。这些新发现将增进我们目前对羟氯喹诱发心肌病的病理学及其对风湿性疾病治疗影响的认识。

相似文献

1
New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.羟氯喹诱导的心肌病的新临床和超微结构发现——2例报告
Hum Pathol. 2007 Dec;38(12):1858-63. doi: 10.1016/j.humpath.2007.06.013.
2
Hydroxychloroquine: a treatable cause of cardiomyopathy.羟氯喹啉:一种可治疗的心肌病病因。
J Am Coll Cardiol. 2012 Aug 21;60(8):786. doi: 10.1016/j.jacc.2011.12.060.
3
Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.一名39岁系统性红斑狼疮合并收缩功能障碍女性患者的羟氯喹诱导的心脏毒性。
J Am Soc Echocardiogr. 2005 Sep;18(9):981. doi: 10.1016/j.echo.2005.01.012.
4
Hydroxychloroquine-induced restrictive cardiomyopathy.羟氯喹诱导的限制性心肌病。
Eur J Echocardiogr. 2007 Aug;8(4):247-51. doi: 10.1016/j.euje.2006.02.002. Epub 2006 Apr 5.
5
Evidence for risk of cardiomyopathy with hydroxychloroquine.羟氯喹啉致心肌病风险的证据。
Lupus. 2012 Dec;21(14):1594-6. doi: 10.1177/0961203312462757. Epub 2012 Oct 4.
6
Hydroxychloroquine-induced cardiomyopathy: a case report.羟氯喹诱导的心肌病:一例报告
Circ Heart Fail. 2011 Mar;4(2):e7-8. doi: 10.1161/CIRCHEARTFAILURE.110.959916.
7
Fatal antimalarial-induced cardiomyopathy: report of 2 cases.致命性抗疟药诱导性心肌病:2 例报告。
J Clin Rheumatol. 2012 Oct;18(7):363-6. doi: 10.1097/RHU.0b013e31826852db.
8
Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.通过心内膜心肌活检诊断氯喹心肌病。
N Engl J Med. 1987 Jan 22;316(4):191-3. doi: 10.1056/NEJM198701223160405.
9
Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis.羟氯喹诱发的局限性皮肤型系统性硬化症患者的心肌病
Clin Res Cardiol. 2017 Mar;106(3):234-236. doi: 10.1007/s00392-016-1064-z. Epub 2016 Dec 21.
10
Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.羟氯喹诱导性心肌病:病例报告、病理生理学、诊断和治疗。
Can J Cardiol. 2014 Dec;30(12):1706-15. doi: 10.1016/j.cjca.2014.08.016. Epub 2014 Aug 23.

引用本文的文献

1
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications.系统性硬化症中的心肌病:最新进展与临床意义
Curr Cardiol Rep. 2025 Jan 4;27(1):3. doi: 10.1007/s11886-024-02164-w.
2
Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis.采用标准和先进超声心动图技术评估系统性红斑狼疮患者的左心室收缩功能:一项系统评价和荟萃分析。
Arch Rheumatol. 2024 Jan 29;39(1):149-158. doi: 10.46497/ArchRheumatol.2024.10131. eCollection 2024 Mar.
3
Impairment of substrate-mediated mitochondrial respiration in cardiac cells by chloroquine.
氯喹抑制心肌细胞中底物介导的线粒体呼吸。
Mol Cell Biochem. 2024 Feb;479(2):373-382. doi: 10.1007/s11010-023-04740-0. Epub 2023 Apr 19.
4
Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations.利用全心光学映射和模拟量化羟氯喹和阿奇霉素的心律失常性长QT效应。
Heart Rhythm O2. 2021 Jul 3;2(4):394-404. doi: 10.1016/j.hroo.2021.06.008. eCollection 2021 Aug.
5
Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.揭示一名心力衰竭和变时性功能不全患者的羟氯喹心脏毒性
JACC Case Rep. 2021 May 26;3(7):997-1001. doi: 10.1016/j.jaccas.2021.03.003. eCollection 2021 Jul 7.
6
Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19.归因于羟氯喹的心脏并发症:COVID-19 之前的文献系统综述
Curr Cardiol Rev. 2021;17(3):319-327. doi: 10.2174/1573403X16666201014144022.
7
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.氯喹和羟氯喹在 COVID-19 和其他病毒感染中的治疗用途:叙述性综述。
Travel Med Infect Dis. 2020 May-Jun;35:101735. doi: 10.1016/j.tmaid.2020.101735. Epub 2020 May 6.
8
Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues.拓展氯喹、羟氯喹及相关结构类似物临床应用的视野。
Drugs Context. 2019 Nov 25;8. doi: 10.7573/dic.2019-9-1. eCollection 2019.
9
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.氯喹和羟氯喹相关的心脏并发症:文献系统综述。
Drug Saf. 2018 Oct;41(10):919-931. doi: 10.1007/s40264-018-0689-4.
10
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.目前及未来在感染性、免疫性、肿瘤性和神经退行性疾病中应用氯喹和羟氯喹:小型综述。
Clin Drug Investig. 2018 Aug;38(8):653-671. doi: 10.1007/s40261-018-0656-y.